Company news
Edwards Lifesciences Corporation (NYSE:EW) news
Edwards Lifesciences Corporation news releases on 6ix. Latest, Oct 5, 2026: Edwards Lifesciences to Host Investor Event in Conjunction With TCT
Press releases & updates
Edwards Lifesciences to Host Investor Event in Conjunction With TCT
October 5, 2026
Edwards Lifesciences Receives FDA Approval for AUTUS Valve, the First Surgical Pulmonary Valve for Pediatric Patients
October 1, 2026
Edwards Lifesciences Comments on TAVR National Coverage Decision
September 10, 2026
Edwards Lifesciences to Present at the Deutsche Bank Healthcare Summit
September 2, 2026
Edwards Lifesciences to Host Earnings Conference Call on July 23, 2026
July 16, 2026
Edwards’ Structural Heart Leadership Demonstrated Through Expanding Body of Scientific Evidence at New York Valves
June 26, 2026
Edwards Lifesciences Announces Appointment of CFO
May 4, 2026
TEN-YEAR PIVOTAL DATA REINFORCE THE LONG-TERM DURABILITY OF EDWARDS' RESILIA TISSUE
May 4, 2026
Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences’ Resilia Tissue
May 2, 2026
Edwards Lifesciences to Present at the BofA Securities 2026 Health Care Conference
April 28, 2026
Edwards Lifesciences to Host Earnings Conference Call on April 23, 2026
April 16, 2026
Two Year Data on Edwards Lifesciences’ EVOQUE System Continue to Demonstrate Significant and Sustained Patient Benefits
March 30, 2026
Edwards Lifesciences Advances Structural Heart Care Through Innovation and Purpose
February 26, 2026
NEW SURVEY BY EDWARDS LIFESCIENCES UNCOVERS JUST HOW MUCH AMERICANS KNOW ABOUT THEIR HEART HEALTH
February 24, 2026
Edwards Lifesciences to Present at the Barclays and Leerink Partners Global Healthcare Conferences
February 19, 2026
Edwards Lifesciences to Present at Citi’s 2026 Unplugged Medtech and Life Sciences Access Day
February 13, 2026
Edwards Lifesciences Reports Fourth Quarter Results
February 10, 2026
Edwards Lifesciences to Host Earnings Conference Call on February 10, 2026
February 3, 2026
Edwards Lifesciences to Present at the TD Cowen 46th Annual Health Care Conference
February 2, 2026
Edwards Comments on JenaValve Acquisition
January 9, 2026
FDA Approves Edwards Lifesciences' SAPIEN M3 Mitral Valve Replacement System as First Transseptal Transcatheter Therapy
December 23, 2025
Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 18, 2025
Edwards Lifesciences Reaffirms Strategy for Sustainable, Differentiated Growth at Annual Investor Conference
December 4, 2025
Edwards Champions American Heart Association Initiative to Reduce Deaths, Improve Care for Patients With Heart Valve Disease
November 9, 2025
Edwards Lifesciences Announces CFO Transition Plan
October 30, 2025
Edwards Lifesciences Reports Third Quarter Results
October 30, 2025
Successful Patient Outcomes Demonstrated With Edwards’ SAPIEN M3 and EVOQUE Systems, New Data Presented at TCT 2025
October 27, 2025
Edwards SAPIEN 3 TAVR Delivers Proven Long-term Benefits and Valve Performance, New Data Presented at TCT 2025
October 27, 2025
Edwards Lifesciences to Host Earnings Conference Call on October 30, 2025
October 23, 2025
Updated ESC/EACTS Guidelines Mark Advancement in Structural Heart Disease Care
August 29, 2025
Pulnovo Medical Names Dr. Francis Duhay as Global Chief Medical Officer
August 25, 2025
Edwards Lifesciences Announces $500 Million Accelerated Share Repurchase
August 19, 2025
Edwards Lifesciences Comments on FTC’s Action to Block Proposed Acquisition of JenaValve
August 6, 2025
Edwards Lifesciences Reports Second Quarter Results
July 24, 2025
Edwards Lifesciences to Host Earnings Conference Call on July 24, 2025
July 18, 2025
Prompt Intervention for Severe Aortic Stenosis Patients Demonstrates Lower Healthcare Costs, Improved Clinical Outcomes
May 22, 2025
Edwards Lifesciences to Present at the BofA Securities 2025 Health Care Conference
May 6, 2025
Edwards TAVR Receives FDA Approval for Patients With Asymptomatic Severe Aortic Stenosis
May 1, 2025
Edwards Lifesciences Reports First Quarter Results
April 23, 2025
Eight-Year Data Confirm Long-Term Durability of Edwards’ RESILIA Tissue
April 18, 2025
Edwards Lifesciences to Host Earnings Conference Call on April 23, 2025
April 16, 2025
Edwards SAPIEN M3 Receives CE Mark, Becoming World’s First Transfemoral Transcatheter Mitral Valve Replacement System
April 14, 2025
New Data Confirm Rapid, Unpredictable Progression of Severe Aortic Stenosis and Need for Urgent Referral and Evaluation of Patients
March 31, 2025
Edwards Lifesciences to Present at the TD Cowen 45th Annual Health Care Conference
February 25, 2025